
Cayuga Venture Fund

Investment firm backing smaller biopharmaceutical companies developing genetic and cellular medicines

Commodore Capital is an investment firm focused on biopharmaceuticals. It believes the industry is at the start of a major innovation cycle, driven by scientific discoveries reaching the clinic.
Biopharma investment — capital for companies working to bring new medicines to patients.
Partnership approach — aims to be a supportive partner as those companies develop safe and effective treatments.
Scientific view — treats new therapy types such as genetic medicines and cellular therapies as the source of coming clinical advances.
Smaller biopharmaceutical companies. The firm notes that much research now happens outside large drug makers, and it points to genetic medicines and cellular therapies as the new treatment types driving change.
Profile written by TrustList from the business's own published information, Oct 2026.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Commodore Capital.
Similar listings buyers compare against this one.

Cayuga Venture Fund

Nigerian financial services group covering trading, investment management, lending and early-stage investing

Healthcare venture firm investing in medical device, pharmaceutical and therapy companies with experienced management teams

Regulated UK private equity house investing in growing technology and consumer businesses

A seed and early-stage venture firm backing digital companies in essential industries such as healthcare and energy

Kinetic Partners
Everything here links back to the same verified catalogue. Pick your next stop.